ZEFAMENIB

UNII:	L25B98F8W3
Type:	INGREDIENT SUBSTANCE
Formula:	C₃₁H₃₅FN₈O₂
Preferred Substance Name:	ZEFAMENIB
InChIKey:	XDXAYPYOHXUEAM-CLHVYKLBSA-N
GSRS Full Record:	L25B98F8W3 i

2938995-50-5
(2-(6-(2-(4-cyclopropylpyrimidin-5-yl)-4-fluorophenoxy)-1,2,4-triazin-5-yl)-2,7-diazaspiro[3.5]nonan-7-yl)((1S,3aR,6aS)-octahydrocyclopenta[c]pyrrol-1-yl)methanone
BN-104
BN104
Methanone, [2-[6-[2-(4-cyclopropyl-5-pyrimidinyl)-4-fluorophenoxy]-1,2,4-triazin-5-yl]-2,7-diazaspiro[3.5]non-7-yl][(1S,3aR,6aS)-octahydrocyclopenta[c]pyrrol-1-yl]-
Zefamenib
[(3S,3aS,6aR)-1,2,3,3a,4,5,6,6a-octahydrocyclopenta[c]pyrrol-3-yl]-[2-[6-[2-(4-cyclopropylpyrimidin-5-yl)-4-fluorophenoxy]-1,2,4-triazin-5-yl]-2,7-diazaspiro[3.5]nonan-7-yl]methanone
zefamenib [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ZEFAMENIB

Synonyms and Mappings

Resources